SCHEMBL22339347

SCHEMBL22339347

Cc1nc(C(C)(C)C)c2ccccn12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SSTR4 P31391 3/20 0.48
ALDH1A1 P00352 5/20 0.44
KDM4E B2RXH2 5/20 0.44
MAPT P10636 3/20 0.44
KMT2A Q03164 3/20 0.44
MEN1 O00255 2/20 0.44
LMNA P02545 1/20 0.44
PTPN1 P18031 2/20 0.42
PTPN2 P17706 1/20 0.42
GAA P10253 3/20 0.36
HPGD P15428 3/20 0.36
NPC1 O15118 2/20 0.36
GLA P06280 1/20 0.36
CASP1 P29466 1/20 0.36
CASP7 P55210 1/20 0.36
HSD17B10 Q99714 1/20 0.36
RAB9A P51151 1/20 0.36
NPSR1 Q6W5P4 2/20 0.35
HTT P42858 2/20 0.34
MAPK1 P28482 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16256030 0.85 SSTR4 (0.46) SSTR4ALDH1A1KDM4EMAPTKMT2A
SCHEMBL14584038 0.83 SSTR4 (0.41) SSTR4ALDH1A1KDM4EMAPTKMT2A
SCHEMBL14614237 0.79 MAPT (0.51) SSTR4ALDH1A1KDM4EMAPTKMT2A
SCHEMBL21180167 0.79 SSTR4 (0.39) SSTR4ALDH1A1KDM4EMAPTKMT2A
SCHEMBL8234959 0.78 PTPN1 (0.60) SSTR4ALDH1A1KDM4EMAPTKMT2A
SCHEMBL21180175 0.78 MEN1 (0.41) SSTR4ALDH1A1KDM4EMAPTKMT2A
SCHEMBL21894543 0.76 CNR2 (0.53) SSTR4ALDH1A1KDM4EMAPTKMT2A
SCHEMBL20674534 0.76 PTPN2 (0.44) SSTR4ALDH1A1KDM4EMAPTKMT2A
SCHEMBL17520300 0.74 PTPN2 (0.43) SSTR4ALDH1A1KDM4EMAPTKMT2A
SCHEMBL19100335 0.74 PTPN1 (0.43) SSTR4ALDH1A1KDM4EMAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240067641-A1 INHIBITORS OF TRIM33 AND METHODS OF USE DANA-FARBER CANCER INSTITUTE, INC. (US) 2024-02-29 US disclosed
US-11820766-B2 Monoacylglycerol lipase modulators JANSSEN PHARMACEUTICA NV (BE) 2023-11-21 US disclosed
US-11731967-B2 Inhibitors of TRIM33 and methods of use DANA-FARBER CANCER INSTITUTE, INC. (US) 2023-08-22 US disclosed
US-11731967-B2 Inhibitors of TRIM33 and methods of use DANA-FARBER CANCER INSTITUTE, INC. (US) 2023-08-22 US disclosed
US-20230145249-A1 Monoacylglycerol Lipase Modulators JANSSEN PHARMACEUTICA NV (BE) 2023-05-11 US disclosed
US-20200255422-A1 INHIBITORS OF TRIM33 AND METHODS OF USE DANA-FARBER CANCER INSTITUTE, INC. (US) 2020-08-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11731967-B2 Inhibitors of TRIM33 and methods of use TRIM33, TRIM28, TRIM4 SSTR4 4883/4885ALDH1A1 3246/4885KDM4E 1284/4885
US-20230145249-A1 Monoacylglycerol Lipase Modulators MGLL, LPL, PNLIP SSTR4 2673/4885ALDH1A1 312/4885KDM4E 2437/4885
US-20200255422-A1 INHIBITORS OF TRIM33 AND METHODS OF USE TRIM33, TRIM28, TRIM4 SSTR4 4883/4885ALDH1A1 3246/4885KDM4E 1284/4885
US-20240067641-A1 INHIBITORS OF TRIM33 AND METHODS OF USE TRIM33, TRIM28, TRIM4 SSTR4 4883/4885ALDH1A1 3246/4885KDM4E 1284/4885
US-11820766-B2 Monoacylglycerol lipase modulators MGLL, LPL, PNLIP SSTR4 2673/4885ALDH1A1 312/4885KDM4E 2437/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.